Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004940480 | SCV005615263 | uncertain significance | not specified | 2024-12-10 | criteria provided, single submitter | clinical testing | The c.664C>T (p.R222C) alteration is located in exon 5 (coding exon 3) of the LRTM2 gene. This alteration results from a C to T substitution at nucleotide position 664, causing the arginine (R) at amino acid position 222 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |